Skip to main content

Table 1 Comet assay

From: Co-expression of low-risk HPV E6/E7 and EBV LMP-1 leads to precancerous lesions by DNA damage

 

Comet length (μm ± SD)

Positive rate (%)

mock

116.5 ± 40.9

17%

LMP-1

167.8 ± 45.3

26%

6E6

181.0 ± 51.9

37%

6E6 + LMP-1

190.2 ± 38.5

38%

16E6

159.9 ± 28.7

35%

16E6 + LMP-1

190.4 ± 29.5

41%